Comparison of one and three initial monthly intravitreal ranibizumab injection in patients with macular edema secondary to branch retinal vein occlusion | Zendy

Alper Halil Bayat | Zendy; Akın Çakir | Zendy; Gülcenur Özturan | Zendy; Selim Bölükbaşı | Zendy; Burak Erden | Zendy; Mustafa Nuri Elçioğlu | Zendy

Open Access

Comparison of one and three initial monthly intravitreal ranibizumab injection in patients with macular edema secondary to branch retinal vein occlusion

Author(s) -

Alper Halil Bayat,

Akın Çakir,

Gülcenur Özturan,

Selim Bölükbaşı,

Burak Erden,

Mustafa Nuri Elçioğlu

Publication year - 2018

Publication title -

international journal of ophthalmology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.634

H-Index - 29

eISSN - 2227-4898

pISSN - 2222-3959

DOI - 10.18240/ijo.2018.09.17

Subject(s) - medicine , pro re nata , branch retinal vein occlusion , ophthalmology , macular edema , ranibizumab , external limiting membrane , visual acuity , optical coherence tomography , retinal , occlusion , internal limiting membrane , surgery , bevacizumab , vitrectomy , macular hole , retinal pigment epithelium , chemotherapy

To compare three initial monthly intravitreal ranibizumab (IVR) injections followed by pro re nata (PRN) dosing with one initial monthly IVR injections followed by PRN dosing for macular edema (ME) secondary to branch retinal vein occlusion (BRVO).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research